malocclusion
Conditions
Interventions
Orthodontic treatment
Sponsors
Kanetaka Hiroyasu
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients who voluntarily consented in writing to participate in this clinical trial (parental authority for minors) (2) Malocclusion (excluding skeletal malocclusion requiring orthodontic treatment) and no congenital anomalies. (3) Male and Female between the ages of 13 and 37 at the time of informed consent (4) Patients who are judged to have finished or about to finish pubertal growth. (Determined by X-rays of carpal bones, etc.)
Exclusion criteria
Exclusion criteria: (1) Jaw deformity patients and congenital syndrome patients (2) Patients intended for stage I treatment (3) Patients who have experienced orthodontic treatment (4) Patients who are expected to have difficulty in continuing treatment at Tohoku University Hospital until the end of treatment (5) Patients with vomiting reflex that makes impression taking difficult (6) Female who are pregnant, may be pregnant, have given birth within 28 days, or are breastfeeding (7) Patients who are considered difficult to participate in the study due to complication of psychosis or psychiatric symptoms (8) In addition, patients who are judged to be inappropriate as subjects by the principal investigator or co-investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| duration of orthodontic treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of visits during the treatment period Time spent on bonding Bracket dropout rate Study model evaluation before and after treatment Concordance rate with treatment goals VAS score Evaluation of occlusal stability one year after device removal | — |
Contacts
Public ContactArata Ito
Tohoku University Hospital
Outcome results
None listed